v3 Template
B

Bicara Therapeutics Inc.

Biotechnology / Healthcare Boston, USA ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$950.0M
Funding Rounds
4
Last Funding
2024-09-16

About Bicara Therapeutics Inc.

Bicara Therapeutics is a company dedicated to improving the lives of people with cancer by developing innovative targeted therapies. Their mission is to deliver first-in-class treatments that provide meaningful and durable benefits to patients, combining the precision of targeted therapies with tumor-microenvironment modulators.

Products & Services

Ficerafusp alfa (BCA101):A first-in-class, dual-action, bifunctional EGFR/TGF-β antibody in clinical development for multiple solid tumor cancer types, including head and neck squamous cell carcinoma (HNSCC).

Specialties

Oncology drug development Targeted therapies Tumor-microenvironment modulators First-in-class treatments for solid tumor cancers

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Initial Public Offering
T: -
FT: Initial Public Offering
A: 362000000
MR: -
FA: approximately $362 million
FAN: 362000000
D: 2024-09-16
FD: 2024-09-16
4 investors
2 RT: IPO
T: -
FT: IPO
A: 315000000
MR: -
FA: approximately $315.00 million
FAN: 315000000
D: 2024-09-12
FD: 2024-09-12
4 investors
3 RT: Series C
T: -
FT: Series C
A: 165000000
MR: -
FA: $165 million
FAN: 165000000
D: 2023-12-12
FD: 2023-12-12
5 investors
4 RT: Series B
T: -
FT: Series B
A: 108000000
MR: -
FA: 108 million
FAN: 108000000
D: 2023-03-06
FD: 2023-03-06
11 investors
Initial Public Offering Latest
2024-09-16
$362.0M
4 investors (Pro only)
IPO 2024-09-12
$315.0M
Series C 2023-12-12
$165.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Claire Mazumdar

Chief Executive Officer

R

Ryan Cohlhepp

President & Chief Operating Officer

I

Ivan Hyep

Chief Financial Officer

D

David Raben

Chief Medical Officer

L

Lara Meisner

Chief Legal Officer

P

Pauline Dufresne

Chief People Officer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Bicara Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
bicara.com
Industries
Biotechnology / Healthcare
Company Size
~360 employees (est.)
Locations
Boston, USA
Boston

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro